New Developments in Depression and Anxiety Disorders

Burgeoning advances in the neurosciences have been increasingly applied to psychopharmacology, and the reports that follow provide a glimpse into this process. Several of the leading investigators on the cutting edge of this rapidly evolving field have given considerable thought to how, in view of these advances, we conceptualize disorders not only in terms of pathophysiology but also in terms of implications for treatment. The result is a treat for the readers of Psychopharmacology Bulletin. In the space below, I briefly adumbrate the content of these manuscripts, highlighting their major points.